最新更新 :
19/11/2024
研究小組 - Faculty of Medical and Health Sciences, University of Auckland   PDF  
新西蘭
大學
Faculty of Medical and Health Sciences, University of Auckland
Auckland
引用文献   引用文献   (5)  
1
The Effect of Manufacturer on the Compounding of Omeprazole Suspensions and Their Stability Assessment.
Meissner S, Bansal M, Donamae P, Hanning S, Svirskis D. (d.svirskis@auckland.ac.nz)
Int J Pharm Compound - 2020 - ;24,2:140-147
2
Stability of vincristine sulfate, doxorubicin hydrochloride and etoposide phosphate admixtures in polyisoprene elastromeric pump supporting transition of the EPOCH regimen to oupatient care.
Svirskis D, Behera S, Naidoo N, Beachman J, Raina T, Zhou Y, Berkahn L, Costello I, Gu Y. (y.gu@auckland.ac.nz)
J Oncol Pharm Practice - 2018 - ;25,4:831-840.
3
The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D, Lin S.W, Brown H, Sangaroothong A, Wang Z, Xu H, Dean R, Vareed P, Jensen M, Wu Z. (z.wu@auckland.ac.nz)
Int J Pharm Compound - 2018 - ;22,2:164-171
4
An investigation into the stability and sterility of citric acid solutions used for cough reflex testing.
Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D. (d.svirskis@auckland.ac.nz)
Dysphagia - 2014 -
5
Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding.
Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S. ()
Int J Pharm Compound - 2009 - ; 13, 3: 250-253.

药品清单   分子研究   (6)  
其它 气雾剂 Citric acid
抗癌藥物 注射液 Doxorubicin hydrochloride
抗癌藥物 注射液 Etoposide phosphate
激素 口服剂 Levothyroxine
质子泵抑制剂 口服剂 Omeprazole sodium
抗癌藥物 注射液 Vincristine sulfate

  Mentions Légales